YanAn Bicon Pharmaceutical Listed Company reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 1,210.9 million compared to CNY 2,259.44 million a year ago. Revenue was CNY 1,210.9 million compared to CNY 2,259.44 million a year ago.

Net loss was CNY 148.57 million compared to net income of CNY 269.7 million a year ago. Basic loss per share from continuing operations was CNY 0.097 compared to basic earnings per share from continuing operations of CNY 0.176 a year ago. Diluted loss per share from continuing operations was CNY 0.097 compared to diluted earnings per share from continuing operations of CNY 0.176 a year ago.